3839.HK · CPBIO
Hong Kong · RS rating 53 · As of 2026-10-14
| Price | 7.88 HKD |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 53 / 31 / 29 / 63 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 35 / 56 / 26 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +18.7% |
| Market cap (USD) | $242.9M |